You have been chosen to receive this valuable information.
Peter Marks, MD, PhD, Director, CBER, U.S. FDA, Louis Schmukler, SVP & President, Global Product Development and Supply, Bristol-Myers Squibb, and Marschall S. Runge, MD, PhD, Executive Vice President for Medical Affairs, University of Michigan, will headline an esteemed lineup of keynote speakers at the 2019 PDA/FDA Joint Regulatory Conference.
These distinguished speakers will be joined by a slate of regulators and industry-leading speakers who will share their insights on how you can improve the continued supply of high-quality drugs, biologics, and novel combination products to patients.
When you attend this premier pharmaceutical quality conference, you can take advantage of:
An audience of nearly 1,000 industry professionals convening to learn and network
The opportunity to engage with more than 50 regulators, including senior officials from the U.S. FDA and MHRA
Information exchange through your choice of nearly 50 plenary, breakout, breakfast, and interest group sessions, including FDA Center and Compliance Updates and the new Lunch with the Regulators
More than 50 exhibitors showcasing the latest products and solutions
Don’t miss this once-a-year opportunity to find out how innovation is being used to address the supply of high-quality medical products for patients.
Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of BioPharm International, a UBM publication. You are on the mailing list as %%emailaddress%%.
